Biosig issues shareholder letter with corporate update on recent achievements and anticipated milestones for 2021

Westport, ct, march 29, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) (“biosig” or the “company”), a medical technology company commercializing a proprietary biomedical signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that the company had issued a letter to shareholders providing highlights on the company's recent developments and updates.
BSGM Ratings Summary
BSGM Quant Ranking